I have posted once before re BXN. I suspect that after such a sterling run, there are serious profit takers at work.I hope they are not just panicking., I feel compelled to dispel a little confusion there is with some other posters. 1 - The comparison with Vitura and ECS is wrong. Vitura is focused on patients and clinics. They also have had a very public spat. with the senior shareholder selling out and litigating. 2-Ecs really is a farmer. That brings potential high overheads in Australia- A Capital hungy model.-growing and selling a specific brand. 3- The only real comparison is Australian Cannabis Group. Reputation??? 4- BXN is really a story about COGS,scale and efficiency.. They will do a good job with white labels and brands. Plus you get the international aspect of the business . I think there will be major movement there in the next 2 years. My understanding of the market is that Australian clinics and middlemen have been crying out for a local, reliable Australian supplier. It will be interesting to see what the Company reports for H1- results. They should be out soon. I do agree that the enthusiam of the market may have got a little ahead of itself, however they are now a screaming bargain in my opinion. I continue to hold.
BXN Price at posting:
2.7¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)